The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,424.00
Bid: 2,427.00
Ask: 2,428.00
Change: -40.00 (-1.62%)
Spread: 1.00 (0.041%)
Open: 2,450.00
High: 2,459.00
Low: 2,424.00
Prev. Close: 2,464.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management Board Changes

31 Aug 2017 07:00

RNS Number : 3648P
British American Tobacco PLC
31 August 2017
 

31 August 2017

 

British American Tobacco

Management Board Changes

 

 

Following the successful completion of the acquisition of Reynolds American Inc. ("Reynolds American"), we have decided to simplify our regional structure and to fully integrate our Next Generation Products ("NGPs") business into the core operations of the Group - reflecting the outstanding growth of this part of our business to date and its long term importance to the Group's future.

 

As previously announced, Debra Crew joined the Management Board as President and CEO of Reynolds American with effect from 27 July 2017, reporting directly to the Chief Executive, Nicandro Durante.

 

We are now pleased to announce that Jack Bowles, Regional Director, Asia-Pacific, will be appointed to the newly created role of Chief Operating Officer for the international business, excluding the United States ("COO"), reporting directly to the Chief Executive, with effect from 1 October 2017. Jack joined the Group in 2004 and has been a member of the Management Board since October 2009.

Our regional organisational structure will be simplified to create the following three new regions:

· Americas and Sub-Saharan Africa (including East & Central Africa; West Africa and South Africa)

· Europe and North Africa (including Russia, Ukraine, Caucasus, Central Asia, Belarus, and Turkey)

· Asia-Pacific and Middle East

Regional Director responsibilities, reporting directly to the COO and continuing as members of the Management Board, will be reorganised as follows, with effect from 1 January 2018:

 

Ricardo Oberlander, Regional Director, Americas, will be appointed Regional Director, Americas and Sub-Saharan Africa. Ricardo joined the BAT Group in 1989 and has been a member of the Management Board since January 2013.

 

Tadeu Marroco, Regional Director, Western Europe, will be appointed Regional Director, Europe and North Africa. Tadeu joined British American Tobacco in Brazil over 20 years ago and has been a member of the Management Board since September 2014.

 

Johan Vandermeulen, Regional Director, EEMEA, will be appointed Regional Director, Asia-Pacific and Middle East. Johan has been with the BAT Group for more than 20 years and joined the Management Board in September 2014.

Now that we have built a successful NGP business which is poised for substantial growth, we will be fully integrating NGP into our existing business infrastructure across the Group - both within the functions and the Regions - to leverage the scale and expertise of the whole Group to drive growth in an area that is fast becoming a key part of our mainstream business. Kingsley Wheaton, Managing Director, Next Generation Products, will manage this integration process.

 

Andrew Gray, Director, Marketing, will be appointed Chief Marketing Officer, reporting directly to the Chief Executive, with effect from 1 October 2017. This expanded role combines the areas of Marketing and R&D, (including Innovation and Product Development) across all categories - combustible cigarettes and NGPs. Andrew has been with the BAT Group for 31 years and has been a member of the Management Board for over 9 years.

 

David O'Reilly, Group Scientific and R&D Director, remains a member of the Management Board, and will report to the Chief Marketing Officer under the new structure.

 

This new structure will enable better, more integrated resource allocation and decision making across geographies and categories. It creates a truly global multi category business, with NGPs embedded at its heart, to drive continued long term success.

 

 

 

ENQUIRIES

 

INVESTOR RELATIONS:

PRESS OFFICE:

Mike Nightingale

Rachael Brierley

+44 20 7845 1180

+44 20 7845 1519

Anna Vickerstaff / Joanne Walia

 

+44 20 7845 2888

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASDLFWSFWSEEA
Date   Source Headline
13th Mar 20237:00 amRNSBranch Register: Dividend Finalisation Information
9th Mar 202310:35 amRNSDirector/PDMR Shareholding
8th Mar 202311:10 amRNSDirector/PDMR Shareholding
3rd Mar 20234:40 pmRNSDirector/PDMR Shareholding
3rd Mar 202310:15 amRNSDirector Declaration
2nd Mar 20234:55 pmRNSAnnual Financial Report
1st Mar 202310:00 amRNSTotal Voting Rights
23rd Feb 202311:15 amRNSDirector/PDMR Shareholding
15th Feb 20236:05 pmRNSDirector Declaration
15th Feb 202310:30 amRNSDirector/PDMR Shareholding
14th Feb 20236:15 pmRNSPublication of Final Terms
13th Feb 202310:00 amRNSDirector/PDMR Shareholding
9th Feb 20234:10 pmRNSPublication of Supplementary Prospectus
9th Feb 20237:03 amRNSFinal Results
6th Feb 202312:35 pmRNSDirector/PDMR Shareholding
6th Feb 202312:30 pmRNSDirector/PDMR Shareholding
6th Feb 202312:25 pmRNSDirector/PDMR Shareholding
6th Feb 202312:20 pmRNSDirector/PDMR Shareholding
6th Feb 202312:15 pmRNSDirector/PDMR Shareholding
3rd Feb 202310:30 amRNSDirector/PDMR Shareholding
1st Feb 202312:00 pmRNSTotal Voting Rights
31st Jan 20237:00 amRNSManagement Board Changes & New Regional Structure
5th Jan 202312:30 pmRNSDirector/PDMR Shareholding
3rd Jan 20235:00 pmRNSBlock listing Interim Review
3rd Jan 20231:00 pmRNSTotal Voting Rights
16th Dec 202210:20 amRNSSecond Price Monitoring Extn
16th Dec 202210:15 amRNSPrice Monitoring Extension
15th Dec 20221:30 pmRNSDirector/PDMR Shareholding
15th Dec 20227:00 amRNSTransaction in Own Shares
14th Dec 20227:00 amRNSTransaction in Own Shares
13th Dec 20227:00 amRNSTransaction in Own Shares
12th Dec 20227:05 amRNSTransaction in Own Shares
12th Dec 20227:00 amRNSBranch Register: Dividend Finalisation Information
9th Dec 20227:00 amRNSTransaction in Own Shares
8th Dec 202212:30 pmRNSDirector/PDMR Shareholding
8th Dec 20227:05 amRNSTransaction in Own Shares
8th Dec 20227:00 amRNS2022 Second Half Pre-Close Trading Update
7th Dec 20227:00 amRNSTransaction in Own Shares
6th Dec 20227:00 amRNSTransaction in Own Shares
5th Dec 20227:00 amRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 202211:20 amRNSTotal Voting Rights
1st Dec 20227:00 amRNSTransaction in Own Shares
30th Nov 20229:30 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSTransaction in Own Shares
29th Nov 20227:00 amRNSTransaction in Own Shares
28th Nov 20227:00 amRNSTransaction in Own Shares
25th Nov 20227:00 amRNSTransaction in Own Shares
24th Nov 20227:00 amRNSTransaction in Own Shares
23rd Nov 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.